An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma
Titel:
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma
Auteur:
Temam, S. Spicer, J. Farzaneh, F. Soria, J.C. Oppenheim, D. McGurk, M. Hollebecque, A. Sarini, J. Hussain, K. Soehrman Brossard, S. Manenti, L. Evers, S. Delmar, P. Di Scala, L. Mancao, C. Feuerhake, F. Andries, L. Ott, M.G. Passioukov, A. Delord, J.P.